WASATCH ADVISORS LP 13D/13G Filings for ARS Pharmaceuticals, Inc. (SPRY)

WASATCH ADVISORS LP 13D and 13G filings for ARS Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
5:58 pm
Purchase
2022-02-1113GARS Pharmaceuticals, Inc.
SPRY
WASATCH ADVISORS LP1,775,690
5.100%
1,775,690increase
(New Position)
Filing